Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtre
Ajouter des filtres








Gamme d'année
1.
Acta Physiologica Sinica ; (6): 70-76, 2017.
Article Dans Chinois | WPRIM | ID: wpr-331591

Résumé

The pain peptide adrenomedullin (AM) plays a pivotal role in pathological pain. The present study was designed to investigate the effect of blockade of AM receptor on bone cancer pain (BCP) and its mechanism. BCP was developed by inoculation of Walker 256 mammary gland carcinoma cells in the tibia medullary cavity of Sprague Dawley rats. The selective AM receptor antagonist AMwas administered intrathecally on 15 d after the inoculation. Quantitative real-time PCR was used to detect mRNA level of CC chemokine ligand 2 (CCL2) in dorsal root ganglion (DRG). Double immunofluorescence staining was used to analyze the localizations of CCL2 and AM in DRG of normal rats. The results showed that, from 6 to15 d after the inoculation, the animals showed significant reduction in the mechanical pain threshold in the ipsilateral hindpaw, companied by the decline in bone density of tibia bone. The expression of CCL2 mRNA in DRG of BCP rats was increased by 3 folds (P < 0.001 vs saline group). Intrathecal administration of AMabolished bone cancer-induced mechanical allodynia and increase of CCL2 mRNA level (P < 0.001). In normal rats, CCL2 was co-localized with AM in DRG neurons. These results suggest that AM may play a role in the pathogenesis of BCP. The increased AM bioactivity up-regulates CCL2 expression in DRG, which may contribute to the induction of pain hypersensitivity in bone cancer.


Sujets)
Animaux , Rats , Adrénomédulline , Pharmacologie , Tumeurs osseuses , Traitement médicamenteux , Chimiokine CCL2 , Métabolisme , Ganglions sensitifs des nerfs spinaux , Hyperalgésie , Traitement médicamenteux , Douleur , Traitement médicamenteux , Seuil nociceptif , Fragments peptidiques , Pharmacologie , Rat Sprague-Dawley , Réaction de polymérisation en chaine en temps réel , Récepteurs à l'adrénomédulline
2.
Acta Physiologica Sinica ; (6): 241-248, 2016.
Article Dans Chinois | WPRIM | ID: wpr-331660

Résumé

This study was designed to investigate the contribution of prostaglandins to the maintenance of inflammatory pain. Inflammation was induced by intraplantar (i.pl.) injection of carrageenan in right hindpaw in rats. Indomethacin (non-selective COX inhibitor) was administered i.pl. 1 h after the carrageenan injection, and paw withdrawal latency (PWL) responding to noxious heat was measured. β-endorphin (β-END) and μ-opioid receptor (MOR) expressed in the inflamed site were examined by using immunocytochemistry, ELISA and RT-PCR techniques. The results showed that indomethacin dose-dependently increased PWL to the levels that were above the baseline on the day 2 and 3, referred to as hypoalgesia. The hypoalgesia was abolished by a local injection of the non-selective opioid receptor inhibitor naloxone methiodide. The number of β-END-positive cells, the content of β-END and the expression of MOR mRNA in the inflammatory site of inflammation model rats were all significantly increased by indomethacin. These results reveal a novel mechanism of prostaglandins for the inhibition of inflammation-induced endogenous opioid activity. This study provides further evidence that inhibition of prostaglandins in inflamed site could be a promising therapy for inflammatory pain.


Sujets)
Animaux , Rats , Analgésiques morphiniques , Carragénane , Indométacine , Inflammation , Naloxone , Douleur , Prostaglandines , Récepteurs aux opioïdes , bêta-Endorphine
3.
Acta Physiologica Sinica ; (6): 431-436, 2015.
Article Dans Chinois | WPRIM | ID: wpr-255929

Résumé

The increase of pronociceptive mediators in the dorsal root ganglia (DRG) and spinal dorsal horn is an important mechanism in the pathogenesis of inflammatory pain and opioid tolerance. Adrenomedullin (AM) belongs to calcitonin gene-related peptide (CGRP) family and has been recently demonstrated to be a pain-related peptide. It has also been shown that the expression and release of AM are increased in the DRG and spinal dorsal horn during inflammation and repeated use of morphine. Intrathecal administration of the selective AM receptor antagonist AM22-52 abolishes inflammatory pain and morphine tolerance, suggesting that enhanced AM receptor signaling in the DRG and spinal dorsal horn contributes to the induction of inflammatory pain and morphine tolerance. The present review highlights the recent developments regarding the involvement of AM in these two disorders. The neurological mechanisms of AM's actions are also discussed.


Sujets)
Animaux , Rats , Adrénomédulline , Pharmacologie , Peptide relié au gène de la calcitonine , Tolérance aux médicaments , Ganglions sensitifs des nerfs spinaux , Inflammation , Traitement médicamenteux , Métabolisme , Morphine , Pharmacologie , Douleur , Traitement médicamenteux , Métabolisme , Fragments peptidiques , Pharmacologie , Rat Sprague-Dawley , Récepteurs à l'adrénomédulline , Métabolisme
4.
Acta Physiologica Sinica ; (6): 463-469, 2015.
Article Dans Chinois | WPRIM | ID: wpr-255924

Résumé

5-hydroxytryptamine (5-HT) released in inflammatory tissues plays a pivotal role in pain hypersensitivity. However, it is not clear whether 5-HT2A receptors in the inflamed tissues mediate this effect. The present study investigated the contribution of 5-HT2A receptors in the periphery to chronic inflammatory pain. Complete Freund's adjuvant (CFA) was injected subcutaneously in the hindpaw of rats. The selective 5-HT2A receptor antagonist ketanserin was given in the inflamed site. Paw withdrawal latency responding to heat or mechanical stimuli was measured. Expression of neuropeptide Y (NPY) in the spinal dorsal horn and dorsal root ganglia (DRG) was assayed using immunohistochemistry technique. The results showed that ketanserin administered in the inflamed site inhibited thermal hyperalgesia in a dose-dependent manner (20, 40 and 80 µg) induced by the intraplantar injection of CFA. Ketanserin given once per day at a dose of 80 µg abolished heat hyperalgesia and also attenuated mechanical allodynia on the third day. CFA injection increased the expression of NPY in superficial laminae of the spinal cord, but not in the DRG. The local treatment of ketanserin completely inhibited CFA-induced increase in NPY expression in superficial laminae of the spinal cord. These results indicated that activation of 5-HT2A receptors in the inflamed tissues was involved in the pathogenesis of inflammatory pain and the blockade of 5-HT2A receptors in the periphery could relieve pain hypersensitivity and normalize the cellular disorder in the spinal dorsal horn associated with pathological pain. The present study suggests that the peripheral 5-HT2A receptors can be a promising target for pharmaceutical therapy to treat chronic inflammatory pain without central nervous system side effects.


Sujets)
Animaux , Rats , Adjuvant Freund , Ganglions sensitifs des nerfs spinaux , Métabolisme , Température élevée , Hyperalgésie , Traitement médicamenteux , Inflammation , Traitement médicamenteux , Kétansérine , Pharmacologie , Neuropeptide Y , Métabolisme , Douleur , Traitement médicamenteux , Mesure de la douleur , Récepteur de la sérotonine de type 5-HT2A , Métabolisme , Sérotonine , Antagonistes des récepteurs 5-HT2 de la sérotonine , Pharmacologie , Corne dorsale de la moelle spinale , Métabolisme
SÉLECTION CITATIONS
Détails de la recherche